The content on this site is intended for healthcare professionals only
ESMO 2017 roundup with Dr Bishal Gyawali (2/2)
The role of tumour marker testing in early diagnosis
Impact of licensing and reimbursement discrepancies on cancer care in Europe and Canada
Returning to work after cancer
Financial and ethical safety in cancer care
Celebrating a 10 year partnership: ecancer and the IEO
Low-value practices in oncology contributing to financial toxicity
The challenge of approving add-on therapies for patients with metastatic cancer
Latest in relapsed and refractory multiple myeloma
ESMO ranking of the clinical benefits of new drugs
Cancer and the workplace
The recent past and near future of drug approvals in Europe
